Data
Markets
Stocks
Indices
Events Calendar
Economy
Economic Indicators
Economic Calendar
Funds
Mutual Funds
ETFs
CEFs
Featured Content
Economic Summary Deck
Economic Summary Deck
Fund Flows by Category
Sector & Industry Data
Tools
Monitor
Dashboard
Watchlists
Alerts
News
Visualize
Fundamental Chart
Scatter Plot
Technical Chart
Report
Report Builder
Talking Points
Email Reports
Research
Stock Screener
Fund Screener
Comp Tables
Timeseries Analysis
Excel
Sectors
Investment Strategies
Manage
Portfolios
Custom Securities
Scenarios
Portfolio Optimizer
Featured Content
Best Performing Mutual Funds of the Last 10 Years
Best Performing Mutual Funds of the Last 10 Years
Dollar-Cost Averaging Scenario
Explore Investment Strategies
Support
Resources
Tutorials
FAQs
Integrations
Financial Glossary
Info
About Us
Contact Us
Product Release Notes
Content
Webinars
Case Studies
Insights & Visuals
Blog
Featured Content
Fund Flows Report
Fund Flows Report
Advisor-Client Communication Survey
YCharts University Training Sessions
Plans
Cancel
Free Trial
Log In

BeiGene Ltd (ONC)

250.47 -2.73 (-1.08%) USD  |  NASDAQ  |  Mar 25, 16:00
250.98 +0.51 (+0.20%) After-Hours: 20:00
Reports
 Actions
Notes
Add to Watchlist
More

BeiGene EV to Revenues

View 4,000+ Financial Data Types:
Add
Browse

EV to Revenues Chart

View EV to Revenues for ONC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Gilead Sciences Inc Upgrade
Leap Therapeutics Inc Upgrade
Catalyst Pharmaceuticals Inc Upgrade
Exelixis Inc Upgrade
Halozyme Therapeutics Inc Upgrade

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade
Quickflows
ONC

Here are some ways to get started.

Settings